STOCKHOLM — A real-world analysis of retrospective data showed that administering more anti-VEGF injections over a 5-year time span to treat macular edema secondary to retinal vein occlusion (RVO) was ...

Patients with type 2 diabetes who received intravitreal anti-vascular endothelial growth factor (VEGF) injections for diabetic retinopathy were more likely to develop systemic adverse events (AEs) ...

Diabetes can lead to vision complications, such as diabetic retinopathy and diabetic macular edema. Anti-VEGF injections can help protect your vision and may even improve your sight. The procedures ...

Please provide your email address to receive an email when new articles are posted on . Mynampati and colleagues measured VEGF levels in 59 eyes of patients with diabetic retinopathy (DR) who had ...

Please provide your email address to receive an email when new articles are posted on . Staurenghi and colleagues conducted a 2-year, retrospective cohort study to assess the overall effectiveness of ...

The FINANCIAL — A common treatment for wet age-related macular degeneration (AMD) may need a second thought by doctors of optometry. A new study suggests, in some cases, that patients’ vision worsens ...

The demand for intravitreal vascular endothelial growth factor (VEGF) inhibitor therapy is forecasted to increase by about 50% over the next 5 years in Denmark, due largely to an aging population, a ...

4DMT Molecular Therapeutics Inc. is looking ahead to phase III as positive data continue to roll out for gene therapy candidate 4D-150 in wet age-related macular degeneration (AMD), with the results ...

The use of anti-vascular endothelial growth factor injections has been linked to an increased risk of mortality in patients with diabetic retinopathy in a new study, sounding a note of caution ...

The FINANCIAL — Too much of a common age-related macular degeneration (AMD) treatment course in one year’s time could inadvertently tip the scales toward another sight-threatening disease, a new study ...